Merck and Ridgeback begin Phase III trial of molnupiravir for Covid-19
Japan seeking supply of Merck's oral COVID-19 drug this year | The Asahi Shimbun: Breaking News, Japan News and Analysis
Insight: Merck's COVID pill is last choice for U.S. patients, global use varies | Reuters
Merck Pharmaceuticals - Chermayeff & Geismar & Haviv
Merck Issues Voluntary Nationwide Recall of CUBICIN® (daptomycin for injection) 500 mg, Lot 934778, Due to Presence of Particulate Matter Identified as Glass Particles - Merck.com
Merck COVID-19 treatment pill authorized by FDA for home use : NPR
Merck's COVID-19 treatment pill molnupiravir submitted to FDA for emergency use authorization - CBS News
Will Merck's Covid-19 pill be available to lower-income countries? - Pharmaceutical Technology
Molnupiravir: long-term safety questions linger as approvals approach - Pharmaceutical Technology
Merck COVID-19 pill 30% effective
Merck (MRK) Molnupiravir Pill Could Change the Fight Against Covid - Bloomberg
Merck expects COVID-19 pill molnupiravir to be effective against Omicron | Reuters
FDA advisory panel narrowly recommends Merck's Covid pill for emergency use
Merck struggles to win European approval for Covid antiviral pill
Gilead, Merck step in to help India's drug manufacturers fight surging COVID-19 outbreak | Fierce Pharma
Merck's (MRK) Covid Drug Linked to Viable, Spreading Mutants, Study Says - Bloomberg
U.S. allows Merck's COVID-19 pill amid safety, variant concerns | Science | AAAS
Merck sues Biden administration over Medicare drug price negotiations
Legavrio COVID-19 Pill by Merck Continues Its Slump | Fierce Pharma
Merck Covid drug linked to virus mutations, study says
Merck's Covid Pill Might Pose Risks for Pregnant Women - The New York Times
Merck's Covid-19 Pill Heavily Used So Far Despite Concerns - WSJ
Merck Covid-19 treatment pill 'a very powerful tool to add to the toolbox'
Cigna, Merck Ink Pay-For-Performance Deal | Hartford Business Journal
